ArticleJournal of virology2019

A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.

Xiaoran Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.